BiomATCan Ltd.: federal grants and contributions: 17 agreements; $1.1M value; 2 departments; 7 programs.
Assay record ASY-CA-04TVQMW1GI · Cite as: Assay Systems, “BiomATCan Ltd.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/biomatcan-ltd/
Commercialize bone graft products
BIOMATCAN is emerging into the bone regenerative industry with unique innovative technology and products to meet the increasing demand in the market with innovative solutions for bone augmentation and reconstructive surgery. The project aims to develop an injectable formulation of bone substitute biomaterlals.
Establish an ISO-standard manufacturing facility
The project aim to help hire skilled people for helping in production of Testing kit.
To obtain certification/licensing for biomaterial
Engage a consultant to develop export marketing strategies and tools
To Provide company with technical resources to respond to its market entry and need for increasing production capacity. Maintain the quality system
The project aims to hire a production assistant to help in manufacturing of medical devices implant in ISO 13485 regulated environment.
To support production scale up of product , meeting QC and GMP requirements, as well as liaising with the end-users, ensuring the users understand product specifications, use and provide overall technical support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The Firm is a Canadian medical device company that develop synthetic Biomaterials for orthopedic and dental applications for Human and animal health market. The Project will bring to the company a new team member with marketing background. He will help the Firm to collect and analyse marketing data from different sources, understand the specific needs of surgeons, collect specific data that will help the Firm to develop new formulation.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
To develop new Biomaterial products through our green process for orthopedic and dental applications. _x000D_ To support our technical team in production and helping in maintaining quality system for development and production of orthopedic and dental biomaterial according to Health Canada and FDA requirement. Production support.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.